Skip to content
Medical Health Aged Care

RACGP calls for free Meningococcal B vaccination program to save lives

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has called on the Western Australian Government to listen to the calls of families across the state and fund a life-saving Meningococcal B vaccination program. 

It comes following Meningitis Centre Australia’s Meningococcal B Memory Tree event today in which the Western Australian Opposition committed to a future Liberal Government funding a comprehensive vaccination program for Meningococcal B. More than 3,000 parents joined a letter-writing petition calling for free vaccinations. 

RACGP Vice President and Western Australia Chair, Dr Ramya Raman, welcomed the Liberal’s commitment to introduce the vaccination. 

“Parents across Western Australia have spoken up and delivered a vital message – we want a free Meningococcal B vaccination program,” she said. 

“The RACGP is backing those calls for a free Meningococcal B vaccine for children two years and under and adolescents aged 15 to 19. We know that this vaccine is safe and effective – it’s the best protection against this deadly disease. Making this vaccine free for kids and at-risk age groups will save lives. 

“As things stand, Western Australia faces a huge gap in immunisation coverage against Meningococcal B, leaving babies, adolescents and young adults vulnerable to this preventable disease.”  

RACGP President, Dr Michael Wright, echoed Dr Raman’s calls. 

“The Government should act now and roll-out a free vaccination program,” he said. 

“Australian parents shouldn’t have to live in fear of their children suffering from this rare but deadly disease. Meningococcal disease can cause severe scarring, loss of limbs, brain damage and death. The statistics show it kills five to 10% of patients and leaves 10 to 20% of survivors with brain damage, hearing loss, or a learning disability. The B strain is the most common cause of invasive meningococcal disease in children, adolescents, and young adults. It hits our vulnerable kids and young people the hardest. 

“Many households are facing a cost-of-living crisis and having to make difficult decisions on the healthcare options they can afford. Families who choose to self-fund vaccinations face a prohibitive cost of up to $200 a dose. When you consider that children and teenagers need two doses, and babies three, you can see how this is simply out of reach for many families. South Australia’s vaccination program cut Meningococcal B rates amongst children by 60%, and by 73% amongst adolescents. So, we know that this program will make a difference. 

We have a safe and effective vaccine for Meningococcal B – it’s the best protection for kids and families; it just needs to be accessible for those most at risk and making it free will help ensure it is.” 

~ENDS 


Contact details:

RACGP spokespeople are available for interviews: 03 8699 0992 / [email protected].

More from this category

  • Medical Health Aged Care
  • 18/05/2025
  • 05:30
Dementia Australia

Join us today for the Melbourne Memory Walk & Jog

What: Dementia Australia’s Melbourne Memory Walk & Jog    When: Sunday, 18 May from 7:30am   Who: More than 2,300 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Special guests Woody Whitelaw and Takaya Honda.   Where: Princes Park, Carlton North.   Dementia Australia spokespeople and local residents are available for interview. Photos and video of previous Memory Walk & Jog events for publication are available for use. For more information visit: https://www.memorywalk.com.au/event/melbourne/home Dementia Australia is the source of trusted information, education and services for the estimated more than 433,300 Australians living with…

  • Contains:
  • Medical Health Aged Care
  • 17/05/2025
  • 17:11
FUJIREBIO

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ ß-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease

—First Blood-Based In-Vitro Diagnostic Test to Receive FDA Clearancefor Patients Being Assessed for Alzheimer’s Disease. — —Availability of Accurate, Accessible, Blood-Based Diagnostic Tests Will…

  • Contains:
  • Medical Health Aged Care
  • 17/05/2025
  • 03:56
Clue

MIT, University of Colorado Denver, and Clue App Publish Largest Women’s Health Study Documenting Air Pollution’s Impact on Menstrual Cycles

Analysis of 2.2 million menstrual cycles tracked in Clue shows connection between pollution exposure and reproductive healthCAMBRIDGE, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Researchers at MIT’s Senseable City Lab and the University of Colorado Denver, in collaboration with the Clue app, have published the largest study of its kind examining the impact of air pollution on menstrual health across multiple countries. The research, just published in The Lancet Planetary Health, analyzed data from 2.2 million menstrual cycles tracked in Clue, across 230 cities in the United States, Mexico, and Brazil. The study found that higher concentrations of fine particulate…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.